Skip to main content
See the whole filing, with its images and exhibits
Contents

Appendix IIOperating Segments

APPENDIX II

Operating Segments for the years ended 31 December 2024, 2023 and 2022

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
​ · ​ · Biopharma · ​ · Diagnostic · ​ · Bio Supplies · ​ · Others · ​ · Intersegments · ​ · Consolidated
​ · 2024 · 2023() · 2022 () · ​ · 2024 · 2023() · 2022() · 2024 · 2023() · 2022() · 2024 · 2023() · 2022() · 2024 · 2023() · 2022() · ​ · 2024 · 2023() · 2022()
Revenues from external customers6,142,5885,558,3015,005,382​644,898670,269671,292215,664159,957146,076209,232203,450250,165——(8,948)​7,212,3826,591,9776,063,967
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Total operating income6,142,5885,558,3015,005,382​644,898670,269671,292215,664​159,957​146,076​209,232​203,450​250,165​—​—​(8,948)​7,212,3826,591,9776,063,967
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Profit/(Loss) for the segment1,271,194886,978768,095​108,829111,694129,96847,793​43,563​114,397​39,435​6,632​(46,809)​—​6,979​35,419​1,467,2511,055,8461,001,070
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Unallocated expenses​​​​​​​​​​​​​​​​​​​(275,236)(273,529)(218,634)
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Operating profit/(loss)​​​​​​​​​​​​​​​​​​​1,192,015782,317782,436
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Finance result​​​​​​​​​​​​​​​​​​​(748,019)(574,374)(442,941)
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Share of profit/(loss) of equity accounted investee​—​—​—​—​—​—​—​—​—​—​(922)​(1,482)​—​—​—​—​(922)​(1,482)
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Income tax expense​​​​​​​​​​​​​​​​​​​(231,190)(43,349)(90,111)
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Profit for the year after tax​​​​​​​​​​​​​​​​​​​212,806163,672247,902
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Segment assets14,232,88913,419,63613,464,608​3,754,8403,528,8613,681,632348,789​380,012​341,876​889,606​1,840,949​766,139​—​—​(6,997)​19,226,12419,169,45818,247,258
Equity-accounted investments68,99657,52941,162​————​—​—​—​364,234​1,456,797​—​—​—​68,996421,7631,497,959
Unallocated assets———​————​—​—​—​—​—​—​—​—​2,110,1211,400,8821,484,367
Total assets​​​​​​​​​​​​​​​​​​​21,405,24120,992,10321,229,584
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Segment liabilities2,323,789​2,459,786​2,494,213​522,822​466,953​425,69381,813​79,678​43,264​514,414​97,840​222,565​—​—​—​3,442,8383,104,2573,185,735
Unallocated liabilities—​—​—​—​—​——​—​—​—​—​—​—​—​—​9,355,37810,374,15110,067,720
Total liabilities​​​​​​​​​​​​​​​​​​​12,798,21613,478,40813,253,455
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Other information:​​​​​​​​​​​​​​​​​​​
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Allocated amortisation and depreciation327,743333,103297,272​64,52265,81764,6829,305​9,280​5,759​15,696​16,162​20,367​—​—​—​417,266424,362388,080
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Unallocated amortisation and depreciation———​————​—​—​—​—​—​—​—​—​20,63022,06022,900
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Allocated expenses that do not require cash payments(5,143)30,198(71,964)​4,6136,99513,639105​136​120​(8,208)​(789)​(206)​—​—​—​(8,633)36,540(58,411)
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Unallocated expenses that do not require cash payments———​————​—​—​—​—​—​—​—​—​(4,310)548(10,770)
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Allocated additions for the year of property, plant & equipment, intangible assets and rights of use373,380359,442507,457​54,57529,10749,8902,128​9,066​98​7,619​3,884​30,192​—​—​—​437,702401,499587,637
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Unallocated additions for the year of property, plant & equipment, intangible assets and rights of use———​————​—​—​—​—​—​—​—​—​40,48848,61859,866

This appendix forms an integral part of note 5 to the consolidated financial statements.

APPENDIX II

GRIFOLS, S.A.AND SUBSIDIARIES

Operating Segments for the years ended 31 December 2024, 2023 and 2022

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
​ · ​ · Spain · ​ · Rest of European Union · ​ · USA + Canada · ​ · Rest of World · ​ · Consolidated
​20242023(*)2022(*)20242023(*)2022(*)20242023(*)2022(*)20242023(*)2022(*)20242023(*)2022(*)
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Net Revenue423,080362,877320,6311,118,258893,050711,5794,087,0303,898,9613,855,6071,584,0141,437,0891,176,1507,212,3826,591,9776,063,967
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Assets by geographical area1,635,4631,190,6061,156,0687,584,2957,055,1816,600,26411,789,97110,966,92411,713,893395,5121,779,3921,759,35921,405,24120,992,10321,229,584
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Other information:
Additions for the year of property, plant & equipment, intangible assets and rights of use56,79653,21660,503155,534​170,763107,030255,575214,227467,81910,28511,91112,151478,190450,117647,503

This appendix forms an integral part of note 5 to the consolidated financial statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.